Levodopa-carbidopa intestinal gel (LCIG) improves dyskinesia in routine clinical practice

An interim analysis of the DUOGLOBE study, presented at the IPMDS 2019 conference, showed sustained improvements in dyskinesia signs and symptoms, measured using the Unified Dyskinesia Rating Scale (UDysRS), with levodopa-carbidopa intestinal gel (LCIG) in routine clinical practice.